Canlyniadau Chwilio - Gordon Rustin

Mireinio'r Canlyniadau
  1. 1
    True

    True gan Tim Meyer, Gordon Rustin

    Cyhoeddwyd 2000
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer?

    CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer? gan Amy Guppy, Gordon Rustin

    Cyhoeddwyd 2002
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours.

    Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. gan Gordon Rustin, Margaret Booth, J. Dent, Sandra Salt, Frances Rustin, K. D. Bagshawe

    Cyhoeddwyd 1984
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Successful management of metastatic and primary germ cell tumors in the brain

    Successful management of metastatic and primary germ cell tumors in the brain gan J. S. Gordon Rustin, E.S. Newlands, Kenneth D. Bagshawe, H. J. RICHARD Begent, S. M. Crawford

    Cyhoeddwyd 1986
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis

    Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis gan Susan Galbraith, Martin A. Lodge, N. Jane Taylor, Gordon Rustin, Søren M. Bentzen, James Stirling, Anwar R. Padhani

    Cyhoeddwyd 2002
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial

    A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical researc... gan Graham M. Mead, M.H. Cullen, Robert Huddart, Peter Harper, Gordon Rustin, Pat Cook, Sally Stenning, Malcolm D. Mason

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Gestational and nongestational trophoblastic tumors distinguished by DNA analysis

    Gestational and nongestational trophoblastic tumors distinguished by DNA analysis gan Rosemary A. Fisher, Edward S. Newlands, A. J. Jeffreys, Geoffrey M. Boxer, Richard H. J. Beǵent, Gordon Rustin, Kenneth D. Bagshawe

    Cyhoeddwyd 1992
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    The efficacy of audiotapes in promoting psychological well-being in cancer patients: a randomised, controlled trial

    The efficacy of audiotapes in promoting psychological well-being in cancer patients: a randomised, controlled trial gan Patrick McHugh, Shôn Lewis, Sarah Ford, E.S. Newlands, Gordon Rustin, R. Charles Coombes, Dean Smith, Séamus O’Reilly, Lesley Fallowfield

    Cyhoeddwyd 1995
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Randomized Trial of Two or Five Computed Tomography Scans in the Surveillance of Patients With Stage I Nonseminomatous Germ Cell Tumors of the Testis: Medical Research Council Trial TE08, ISRCTN56475197—The National Cancer Research Institute Testis Cancer Clinical Studies Group

    Randomized Trial of Two or Five Computed Tomography Scans in the Surveillance of Patients With Stage I Nonseminomatous Germ Cell Tumors of the Testis: Medical Research Council Tria... gan Gordon Rustin, Graham M. Mead, Sally Stenning, P. Vasey, Nina Aass, Robert Huddart, M. Sokal, J. K. Joffe, Stephen Harland, S Kirk

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Secondary tumours following etoposide containing therapy for germ cell cancer

    Secondary tumours following etoposide containing therapy for germ cell cancer gan Chris Boshoff, Richard H. J. Beǵent, R.T.D. Oliver, Gordon Rustin, ES Newlands, RG Andrews, Matthew R. Skelton, L. Holden, J. Ong

    Cyhoeddwyd 1995
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Targeted anti-vascular therapies for ovarian cancer: current evidence

    Targeted anti-vascular therapies for ovarian cancer: current evidence gan Marcia Hall, Charlie Gourley, Iain A. McNeish, Jonathan A. Ledermann, Martin Gore, Gordon C. Jayson, Timothy Perren, Gordon Rustin, Stan B. Kaye

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study

    5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study gan Gordon Rustin, Christopher Bradley, Susan Galbraith, M.R.L. Stratford, Paul M. Loadman, S. Waller, K Bellenger, Lindsey Gumbrell, Lisa K. Folkes, Gavin Halbert

    Cyhoeddwyd 2003
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality Treatment

    Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality Treatment gan Nirupa Murugaesu, Peter Schmid, Gairin Dancey, Roshan Agarwal, L. Holden, Iain A. McNeish, Philip Savage, E.S. Newlands, Gordon Rustin, Michael J. Seckl

    Cyhoeddwyd 2006
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Use of CA-125 in Clinical Trial Evaluation of New Therapeutic Drugs for Ovarian Cancer

    Use of CA-125 in Clinical Trial Evaluation of New Therapeutic Drugs for Ovarian Cancer gan Gordon Rustin, Robert C. Bast, Gary J. Kelloff, J. Carl Barrett, Stephen K. Carter, Perry D. Nisen, Caroline C. Sigman, David Parkinson, Raymond W. Ruddon

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Comparison of CA-125 and Standard Definitions of Progression of Ovarian Cancer in the Intergroup Trial of Cisplatin and Paclitaxel Versus Cisplatin and Cyclophosphamide

    Comparison of CA-125 and Standard Definitions of Progression of Ovarian Cancer in the Intergroup Trial of Cisplatin and Paclitaxel Versus Cisplatin and Cyclophosphamide gan Gordon Rustin, P.J. Timmers, Ann E. Nelstrop, Gavin Shreeves, Søren M. Bentzen, Benoît Baron, Martine Piccart, K. Bertelsen, Gavin Stuart, James T. Cassidy, Elizabeth A. Eisenhauer

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer

    A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer gan Gordon Rustin, Gavin Shreeves, Paul Nathan, Andrew Gaya, Trivadi S. Ganesan, D Wang, J Boxall, L. Poupard, David J. Chaplin, M.R.L. Stratford, Jai Balkissoon, Martin Zweifel

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)

    Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS) gan Ajay K. Kakkar, Mark N. Levine, Zbigniew Kadziola, Nicholas R. Lemoine, V. Warren Low, Heman K. Patel, Gordon Rustin, Michael J. Thomas, Mary Quigley, R C N Williamson

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer)

    Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer) gan Gordon Rustin, Michael Quinn, Tate Thigpen, Andreas du Bois, Éric Pujade-Lauraine, Anders Jakobsen, Elizabeth A. Eisenhauer, Satoru Sagae, Kathryn M. Greven, Ignace Vergote, Andrés Cervantes, Jan B. Vermorken

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer

    Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer gan Martin Zweifel, Gordon C. Jayson, N.S. Reed, Richard H. Osborne, Bassam Abdul Rasool Hassan, Jonathan A. Ledermann, Gavin Shreeves, L. Poupard, S.-P. Lu, Jai Balkissoon, David J. Chaplin, Gordon Rustin

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    O6-Methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma

    O6-Methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma gan MR Middleton, JM Lunn, C. Morris, Gordon Rustin, Stephen R. Wedge, MH Brampton, MJ Lind, Siow Ming Lee, David R. Newell, N M Bleehen, ES Newlands, A. Hilary Calvert, GP Margison, Nicholas Thatcher

    Cyhoeddwyd 1998
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: